Ozempic vs Wegovy vs Mounjaro vs Zepbound: Complete Comparison Guide

If you're starting on a GLP-1 medication or considering one, the names get confusing fast. Ozempic. Wegovy. Mounjaro. Zepbound. Rybelsus. Trulicity. Some are the same drug under different brand names. Some are entirely different molecules. Some are approved for diabetes, some for weight loss, and some for both. The differences matter for efficacy, side effects, dosing, and cost.

This guide breaks down the major GLP-1 medications, what makes each one distinct, and how to think about choosing between them with your doctor.

What Are GLP-1 Medications?

GLP-1 receptor agonists are a class of medications that mimic glucagon-like peptide-1, a hormone your gut produces after eating. They work in several ways: slowing how fast food leaves your stomach, sending fullness signals to your brain, helping your pancreas release insulin, and reducing the production of glucose by the liver.

The class was originally developed to treat type 2 diabetes. The weight loss effects were noticed as a side benefit and eventually became the basis for new approvals specifically for chronic weight management. Today, the same active ingredients are sold under different brand names depending on what they're approved to treat and what dose strengths are available.

Two main active ingredients dominate the GLP-1 market for weight loss: semaglutide and tirzepatide. Tirzepatide is technically a dual agonist, meaning it activates both GLP-1 and GIP receptors. This is why it's sometimes grouped separately, but in practice it sits alongside semaglutide as the leading weight loss medication.

Semaglutide: Ozempic, Wegovy, Rybelsus

Semaglutide is the active ingredient in three brand-name medications.

Ozempic is the semaglutide brand approved for type 2 diabetes management. It's prescribed at doses up to 2 mg weekly, taken as a once-weekly injection. Because it's been on the market longer than the weight-loss approvals, it's the brand most people have heard of. It's often prescribed off-label for weight loss, especially when insurance covers it for diabetes but not for weight loss specifically.

Wegovy is the semaglutide brand approved specifically for chronic weight management. It uses the same molecule as Ozempic but at higher doses (up to 2.4 mg weekly). The FDA approval is for adults with obesity or overweight with at least one weight-related condition, plus adolescents 12 and older with obesity. Wegovy is the FDA-approved version of semaglutide for weight loss.

Rybelsus is the oral form of semaglutide. It's a daily tablet rather than a weekly injection, approved for type 2 diabetes. Doses go up to 14 mg daily. Rybelsus is the only oral GLP-1 medication on the market and is typically less prescribed for weight loss than the injectable forms because the doses available are lower.

The key thing to understand is that Ozempic, Wegovy, and Rybelsus are all semaglutide. The choice between them often comes down to what your insurance covers, what your doctor prescribes, and whether you prefer injection or oral.

Tirzepatide: Mounjaro, Zepbound

Tirzepatide is the dual-agonist molecule sold under two brand names.

Mounjaro is the tirzepatide brand approved for type 2 diabetes. It's prescribed at doses up to 15 mg weekly, taken as a once-weekly injection. Like Ozempic, it's often used off-label for weight loss when diabetes coverage applies.

Zepbound is the tirzepatide brand approved specifically for chronic weight management. It uses the same molecule as Mounjaro, at the same dose levels (up to 15 mg weekly). The FDA approval is for adults with obesity or overweight with at least one weight-related condition.

Mounjaro and Zepbound are the same drug under different brand names. The choice is again about insurance and what's prescribed for your condition.

Other GLP-1 Medications

Saxenda (liraglutide) is an older GLP-1 medication approved for weight loss. It's taken as a daily injection rather than weekly. Liraglutide is also sold as Victoza for diabetes. Saxenda is generally considered less effective than semaglutide or tirzepatide for weight loss and has largely been displaced by the newer medications.

Trulicity (dulaglutide) is a once-weekly GLP-1 approved for type 2 diabetes. It's sometimes used off-label for weight loss but is generally considered less effective for weight loss than semaglutide or tirzepatide.

Bydureon and Byetta (exenatide) are older GLP-1s primarily prescribed for diabetes. They're rarely the first choice for weight loss today.

How They Compare on Weight Loss

Clinical trials have measured weight loss with each medication, though direct head-to-head comparisons are limited and results vary by individual.

In the STEP trials for Wegovy (semaglutide 2.4 mg), participants on average lost around 15% of their body weight over 68 weeks compared to about 2.4% with placebo.

In the SURMOUNT trials for Zepbound (tirzepatide 15 mg), participants on average lost around 20% of their body weight over 72 weeks compared to about 3% with placebo. Tirzepatide has shown greater weight loss on average than semaglutide in the available data.

Mounjaro and Zepbound, being the same drug, show similar results when used at the same dose. Same with Ozempic and Wegovy.

These are averages. Individual results vary enormously based on starting weight, dose tolerated, adherence, diet, exercise, and biological response. Some people lose more than the average. Some lose less. Some lose dramatically more on one medication than another.

How They Compare on Side Effects

The side effect profiles of semaglutide and tirzepatide are similar. Nausea, vomiting, diarrhea, constipation, fatigue, and headaches are common across both.

Some patterns have emerged in real-world use. Tirzepatide tends to be slightly better tolerated than semaglutide for some people, with somewhat less severe nausea. But this isn't universal. Many people tolerate semaglutide perfectly well and find tirzepatide harder, or vice versa.

The injection-site reactions, the dose-titration patterns, and the general digestive side effects look broadly similar across the class. Individual response is what matters most, and it's hard to predict in advance.

How They Compare on Dosing

Semaglutide (Ozempic, Wegovy) is taken as a weekly injection. Standard titration starts at 0.25 mg and increases over months to a maintenance dose of 1 mg to 2.4 mg depending on the brand and indication.

Tirzepatide (Mounjaro, Zepbound) is also a weekly injection. Titration starts at 2.5 mg and increases over months to a maintenance dose of up to 15 mg.

Rybelsus is a daily oral tablet, taken in the morning on an empty stomach 30 minutes before food or other medications.

Saxenda is a daily injection, which makes adherence harder for many people compared to weekly options.

The injection process itself is similar across all the injectable GLP-1s: a pre-filled pen, a small needle, and an injection in the abdomen, thigh, or upper arm. Rotation between sites is recommended.

How They Compare on Cost

Without insurance, the GLP-1 medications are expensive. List prices typically run $900 to $1,400 per month for the brand-name versions in the US. Insurance coverage varies enormously. Some plans cover GLP-1s for diabetes but not for weight loss. Others cover Wegovy and Zepbound for weight loss with prior authorization. Others don't cover them at all.

The manufacturers offer savings programs that can reduce out-of-pocket costs for eligible patients. Compounded versions exist but are subject to regulatory uncertainty and quality concerns, and their availability has been changing as supply shortages of brand-name medications resolve.

Cost is often the deciding factor between medications in practice. The drug your insurance will cover is usually the drug you end up on.

How to Choose Between GLP-1 Medications

This is a conversation to have with your doctor, but a few principles help.

If you have type 2 diabetes, Ozempic, Mounjaro, Trulicity, and Rybelsus are common starting points because they're FDA-approved for that indication and more likely to be covered.

If you're being prescribed for weight loss, Wegovy and Zepbound are the FDA-approved options. Some doctors and insurance plans prescribe Ozempic or Mounjaro off-label for weight loss when the approved versions aren't covered.

If you've tried one medication and it didn't work well or caused intolerable side effects, switching to the other class (semaglutide to tirzepatide or vice versa) is sometimes effective. People who don't respond well to one often respond differently to the other.

If you prefer oral medication, Rybelsus is the only option, though it's typically less effective for weight loss than the injectables.

Cost and coverage are often the deciding factor regardless of preference. Your doctor can help navigate which medication is actually accessible for your situation.

Switching Between Medications

Switching is common and usually straightforward, but it should be done under medical supervision. The general approach is to stop one medication, allow a washout period if needed, and start the new one at the lowest titration dose. Restarting at the bottom of titration is important even if you were at a high dose on the previous medication, because the new molecule may behave differently in your system.

Side effects often spike during the switch, similar to starting fresh. Plan accordingly.

Frequently Asked Questions

Is Ozempic the same as Wegovy?
Yes, both contain semaglutide. The difference is the approved use (Ozempic for diabetes, Wegovy for weight loss) and the dose strengths available.

Is Mounjaro the same as Zepbound?
Yes, both contain tirzepatide. The difference is again the approved use (Mounjaro for diabetes, Zepbound for weight loss).

Which is better, semaglutide or tirzepatide?
On average, tirzepatide produces more weight loss in clinical trials. But individual response varies, and many people do well on semaglutide. The best medication is the one your body tolerates and your doctor prescribes.

Can I take a GLP-1 if I don't have diabetes?
Yes, Wegovy and Zepbound are FDA-approved for weight management in adults who meet certain BMI criteria, with or without diabetes.

How long do I need to take a GLP-1?
For many people, GLP-1s are long-term medications. Stopping often leads to weight regain. The duration of treatment is a decision to make with your doctor based on your goals and circumstances.

Are compounded GLP-1s safe?
Compounded medications have come into the market during periods of shortage. Their safety and consistency vary, and their regulatory status has been changing. Talk to your doctor before using compounded versions.

Final Thoughts

Choosing a GLP-1 medication isn't about picking the strongest drug on paper. It's about matching the right medication to your body, your insurance, and your circumstances, with your doctor's guidance. The differences between semaglutide and tirzepatide matter at the margins. What matters more is finding the one you can stick with and tracking your response carefully.

Whatever medication you end up on, the journey is easier when your data is in one place. Trimm handles dose tracking, side effect patterns, weight trends, and everything else a GLP-1 journey demands, whether you're on Ozempic, Wegovy, Mounjaro, Zepbound, or any of the others.